16829217

Source:http://linkedlifedata.com/resource/pubmed/id/16829217

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0010674, umls-concept:C0022877, umls-concept:C0030705, umls-concept:C0549193, umls-concept:C1979963, umls-concept:C2003903
pubmed:issue	2
pubmed:dateCreated	2007-3-19
pubmed:abstractText	Clinical trials in cystic fibrosis (CF) currently use laboratory-specific reference ranges to evaluate chemistry and hematology measurements. Laboratory-specific normal reference ranges may not accurately reflect what is abnormal but clinically insignificant among CF patients.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/MO1-RR00037
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101128966
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Alanine Transaminase, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents, http://linkedlifedata.com/resource/pubmed/chemical/Aspartate Aminotransferases, http://linkedlifedata.com/resource/pubmed/chemical/CFTR protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Cystic Fibrosis Transmembrane..., http://linkedlifedata.com/resource/pubmed/chemical/Placebos, http://linkedlifedata.com/resource/pubmed/chemical/Tobramycin
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	1569-1993
pubmed:author	pubmed-author:GossChristopher HCH, pubmed-author:KronmalRichard ARA, pubmed-author:Mayer-HamblettNicoleN, pubmed-author:RamseyBonnie WBW, pubmed-author:WilliamsJudyJ
pubmed:issnType	Print
pubmed:volume	6
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	117-23
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:16829217-Adolescent, pubmed-meshheading:16829217-Alanine Transaminase, pubmed-meshheading:16829217-Anti-Bacterial Agents, pubmed-meshheading:16829217-Aspartate Aminotransferases, pubmed-meshheading:16829217-Child, pubmed-meshheading:16829217-Clinical Laboratory Techniques, pubmed-meshheading:16829217-Clinical Trials, Phase III as Topic, pubmed-meshheading:16829217-Cross-Sectional Studies, pubmed-meshheading:16829217-Cystic Fibrosis, pubmed-meshheading:16829217-Cystic Fibrosis Transmembrane Conductance Regulator, pubmed-meshheading:16829217-Double-Blind Method, pubmed-meshheading:16829217-Female, pubmed-meshheading:16829217-Humans, pubmed-meshheading:16829217-Liver Function Tests, pubmed-meshheading:16829217-Longitudinal Studies, pubmed-meshheading:16829217-Male, pubmed-meshheading:16829217-Placebos, pubmed-meshheading:16829217-Reference Values, pubmed-meshheading:16829217-Tobramycin
pubmed:year	2007
pubmed:articleTitle	Laboratory parameter profiles among patients with cystic fibrosis.
pubmed:affiliation	Department of Medicine, University of Washington Medical Center, Seattle, WA 98195, USA. goss@u.washington.edu
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study, Research Support, N.I.H., Extramural